Author

R. Henrique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:DNA methylation· 2 Organism:human· 2 Approach:experimental assay· 1 Organism:mouse· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Jeronimo· 2 shared A. Carrier· 1 shared A. Carvalho· 1 shared A. Delaunay· 1 shared A. Delmas· 1 shared C. Desjobert· 1 shared C. Etievant· 1 shared C. Guimaraes-Teixeira· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Jeronimo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness

A. Carrier, C. Desjobert, L. Ponger, L. Lamant, M. Bustos, J. Torres-Ferreira, R. Henrique, C. Jeronimo, L. Lanfrancone, A. Delmas, G. Favre, A. Delaunay, F. Busato, D. S. B. Hoon, J. Tost, , P. B. Arimondo

The paper identifies a DNA methylation signature associated with melanoma aggressiveness using a multi-step genomic pipeline across different host environments.

bioRxiv · Apr 11, 2022Cancer Biology

A microfluidics-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer

A. Carvalho, C. Guimaraes-Teixeira, V. Constancio, M. Fernandes, C. Macedo-Silva, R. Henrique, F. J. Monteiro, C. Jeronimo

This study develops a microfluidic method for label-free CTC isolation and cfDNA methylation analysis in lung cancer patients, showing improved diagnostic and prognostic potential through biomarker combinations.

bioRxiv · Feb 28, 2022 · PreprintBioengineering